radiopharmaceuticals

Lantheus taps GE HealthCare to sell its PSMA PET tracer in Japan

Lantheus gave GE HealthCare the rights to its Pylarify prostate cancer imaging agent in Japan, which plans to lean on its Nihon Medi-Physics division.

Conor Hale Sep 24, 2025 11:30am

GE HealthCare considering stake sale in China division: report

Sep 18, 2025 2:30pm

FDA flags review of Telix's radiodiagnostic for kidney cancer

Aug 28, 2025 11:20am

Paint brushes sitting on a colorful canvas

Radiopharma biotech Artbio paints path to clinic with $132M

Jul 29, 2025 7:30am

Micrograph showing the most common prostate cancer

Nuclidium raises $99M for copper-based radiopharma pipeline

Jul 10, 2025 5:04am

BerGenBio, following lead drug's failure, merges with Oncoinvent

Jul 1, 2025 7:00am